After graduating from medical school in 1996, Prof. Platzbecker first started medical training in heart surgery. Since 1998, he has been working at the Department of Hematology and Oncology at the University Hospital “Carl Gustav Carus” in Dresden, Germany. Between 2001 and 2003 he completed a 2-year postdoctoral fellowship provided by the Humboldt-foundation at the Fred Hutchinson Cancer Research Center in Seattle, USA. From 2012 to 2018 Prof. Platzbecker held a position of Professor of Hematology at the University Hospital “Carl Gustav Carus” in Dresden and was the head of the section of Hematology as well as chair of the medical ethics committee of the TU Dresden. In 2015 he was appointed as Transcampus Professor of Hematology at the Faculty of Life Sciences and medicine at King’s College London.
Since October 2018 Prof. Platzbecker is heading the Hematology program at the University Hospital in Leipzig as Director of the Medical Clinic I, Hematology and Cell Therapy.
Prof. Platzbecker’s clinical expertise lies in hematological malignancies with a focus on MDS and AML. The main scientific interest involves the translational exploration of innovative treatment options for these patients involving the use of allogeneic hematopoietic stem cell transplantation. He is a member of the steering committee of the SAL study and German MDS group. In 2012 Prof. Platzbecker has co-founded the European Myelodysplastic Syndromes Cooperative Group (EMSCO).